Isolation of a new potential antitumor compound from Wedelia asperrima.
D016604:Aflatoxin B1; D000348:Aflatoxins / Q000494:pharmacology; D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000302:isolation & purification* / Q000633:toxicity; D004224:Diterpenes / Q000302:isolation & purification* / Q000494:pharmacology / Q000633:toxicity; D005260:Female; D006027:Glycosides / Q000302:isolation & purification* / Q000494:pharmacology / Q000633:toxicity; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000188:drug therapy; D010947:Plants, Toxic / Q000032:analysis*; D051381:Rats
D000348:Aflatoxins; D000972:Antineoplastic Agents, Phytogenic; D004224:Diterpenes; D006027:Glycosides; C026130:wedeloside; D016604:Aflatoxin B1